OSCR:NYE-Oscar Health Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 20.99

Change

0.00 (0.00)%

Market Cap

USD 5.25B

Volume

3.32M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 530.79B
ELV Elevance Health Inc

N/A

USD 121.50B
CNC Centene Corp

N/A

USD 38.77B
MOH Molina Healthcare Inc

N/A

USD 19.84B
NEUE NeueHealth Inc

N/A

USD 0.05B
CI Cigna Corp

N/A

N/A
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing OSCR

EDOC:LSE Global X Telemedicine & D.. 4.85 % 0.00 %

N/A

USD 3.87M
EDOG:LSE Global X Telemedicine & D.. 4.85 % 0.00 %

N/A

USD 0.23M
EDOC Global X Telemedicine & D.. 4.24 % 0.00 %

N/A

USD 0.05B
DDOC:XETRA Global X Telemedicine & D.. 3.94 % 0.00 %

N/A

USD 5.39M
DDOC:F Global X Telemedicine & D.. 3.94 % 0.00 %

N/A

USD 4.62M

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 129.40% 100% F 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 129.40% 100% F 93% A
Trailing 12 Months  
Capital Gain 276.84% 100% F 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 276.84% 100% F 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 32.62% N/A N/A 90% A-
Dividend Return 32.62% N/A N/A 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 103.81% N/A N/A 7% C-
Risk Adjusted Return 31.42% N/A N/A 49% F
Market Capitalization 5.25B 33% F 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector